Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

Objectives: The aim of the study was to compare the access of patients with rare diseases (RDs) to biotechnological drugs in several Central and Eastern European countries (CEECs). We focused on the legislative pricing and reimbursement requirements, availability of biotechnological orphan medicinal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Kamusheva, Maria, Manova, Manoela, Savova, Alexandra T., Petrova, Guenka I., Mitov, Konstantin, Harsányi, András, Kaló, Zoltán, Márky, Kristóf, Kawalec, Pawel, Angelovska, Bistra, Lakić, Dragana, Tesar, Tomas, Draganic, Pero, Geitona, Mary, Hatzikou, Magdalini, Paveliu, Marian S., Männik, Agnes
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6062647/
https://ncbi.nlm.nih.gov/pubmed/30079023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00795
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi